000 | 01129 a2200325 4500 | ||
---|---|---|---|
005 | 20250517120930.0 | ||
264 | 0 | _c20170505 | |
008 | 201705s 0 0 eng d | ||
022 | _a1744-8409 | ||
024 | 7 |
_a10.1080/1744666X.2016.1246957 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGalluzzo, M | |
245 | 0 | 0 |
_aBrodalumab for the treatment of psoriasis. _h[electronic resource] |
260 |
_bExpert review of clinical immunology _cDec 2016 |
||
300 |
_a1255-1271 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Interleukin-17 _ximmunology |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aD'adamio, S | |
700 | 1 | _aBianchi, L | |
700 | 1 | _aTalamonti, M | |
773 | 0 |
_tExpert review of clinical immunology _gvol. 12 _gno. 12 _gp. 1255-1271 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/1744666X.2016.1246957 _zAvailable from publisher's website |
999 |
_c26497385 _d26497385 |